Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

(2011) R. J. Kelly et al.   BLOOD

Eculizumab therapy in an adult with plasma exchange-refractory atypical hemolytic uremic syndrome

(2010) Hallie C. Prescott et al.   AMERICAN JOURNAL OF HEMATOLOGY

New insights into postrenal transplant hemolytic uremic syndrome

(2010) Julien Zuber et al.   Nature Reviews Nephrology

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

(2010) Samhar I. Al-Akash et al.   PEDIATRIC NEPHROLOGY

Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome

(2010) Anne-Laure Lapeyraque et al.   PEDIATRIC NEPHROLOGY

Eculizumab: Safety and Efficacy After 17 Months of Treatment in a Renal Transplant Patient With Recurrent Atypical Hemolytic-Uremic Syndrome: Case Report

(2010) V. Châtelet et al.   TRANSPLANTATION PROCEEDINGS

Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome

(2009) C. J. Mache et al.   Clinical Journal of the American Society of Nephrology

Eculizumab for Atypical Hemolytic–Uremic Syndrome

(2009) Jens Nürnberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

(2009) Ralph A. Gruppo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atypical Hemolytic–Uremic Syndrome

(2009) Marina Noris et al.   NEW ENGLAND JOURNAL OF MEDICINE